Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP, and Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP, discuss the use of mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes, including:
Endocrine Clinical Pharmacy Specialist
CGM and Remote Monitoring Program Coordinator
Endocrinology and Metabolism Institute
Vice Chair & Allen I. White Distinguished Professor
Department of Pharmacotherapy
College of Pharmacy and Pharmaceutical Sciences
Washington State University
This program has been made available online.
Dr Geoffrey C. Wall discusses how updated guidelines inform the selection of appropriate therapy for patients with severe asthma, from ProCE
Dr Jamie McConaha discusses the current understanding of atopic dermatitis pathophysiology and the latest biologic therapies used for treatment, from ProCE
Expert commentary and downloadable slides featuring guidance for pharmacists on personalizing care for patients with moderate to severe AD
Slideset with expert insights on the optimal management of severe asthma to improve clinical and economic outcomes from ProCE.